253 related articles for article (PubMed ID: 15065765)
1. Junctional adhesion molecule 1 (JAM-1).
Naik UP; Eckfeld K
J Biol Regul Homeost Agents; 2003; 17(4):341-7. PubMed ID: 15065765
[TBL] [Abstract][Full Text] [Related]
2. Essential role of junctional adhesion molecule-1 in basic fibroblast growth factor-induced endothelial cell migration.
Naik MU; Vuppalanchi D; Naik UP
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2165-71. PubMed ID: 12958043
[TBL] [Abstract][Full Text] [Related]
3. Junctional adhesion molecule-A regulates cell migration and resistance to shear stress.
Huang H; Cruz F; Bazzoni G
J Cell Physiol; 2006 Oct; 209(1):122-30. PubMed ID: 16783819
[TBL] [Abstract][Full Text] [Related]
4. Junctional adhesion molecule (JAM) is phosphorylated by protein kinase C upon platelet activation.
Ozaki H; Ishii K; Arai H; Horiuchi H; Kawamoto T; Suzuki H; Kita T
Biochem Biophys Res Commun; 2000 Oct; 276(3):873-8. PubMed ID: 11027562
[TBL] [Abstract][Full Text] [Related]
5. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1.
Santoso S; Sachs UJ; Kroll H; Linder M; Ruf A; Preissner KT; Chavakis T
J Exp Med; 2002 Sep; 196(5):679-91. PubMed ID: 12208882
[TBL] [Abstract][Full Text] [Related]
6. JAM family and related proteins in leukocyte migration (Vestweber series).
Bradfield PF; Nourshargh S; Aurrand-Lions M; Imhof BA
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2104-12. PubMed ID: 17615384
[TBL] [Abstract][Full Text] [Related]
7. Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion.
Babinska A; Kedees MH; Athar H; Sobocki T; Sobocka MB; Ahmed T; Ehrlich YH; Hussain MM; Kornecki E
Thromb Haemost; 2002 Apr; 87(4):712-21. PubMed ID: 12008956
[TBL] [Abstract][Full Text] [Related]
8. The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity.
Ebnet K; Aurrand-Lions M; Kuhn A; Kiefer F; Butz S; Zander K; Meyer zu Brickwedde MK; Suzuki A; Imhof BA; Vestweber D
J Cell Sci; 2003 Oct; 116(Pt 19):3879-91. PubMed ID: 12953056
[TBL] [Abstract][Full Text] [Related]
9. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes.
Ostermann G; Weber KS; Zernecke A; Schröder A; Weber C
Nat Immunol; 2002 Feb; 3(2):151-8. PubMed ID: 11812992
[TBL] [Abstract][Full Text] [Related]
10. Junctional adhesion molecule-a participates in the formation of apico-basal polarity through different domains.
Rehder D; Iden S; Nasdala I; Wegener J; Brickwedde MK; Vestweber D; Ebnet K
Exp Cell Res; 2006 Oct; 312(17):3389-403. PubMed ID: 16919624
[TBL] [Abstract][Full Text] [Related]
11. Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions.
Itoh M; Sasaki H; Furuse M; Ozaki H; Kita T; Tsukita S
J Cell Biol; 2001 Aug; 154(3):491-7. PubMed ID: 11489913
[TBL] [Abstract][Full Text] [Related]
12. The role of junctional adhesion molecule C (JAM-C) in acute pancreatitis.
Vonlaufen A; Aurrand-Lions M; Pastor CM; Lamagna C; Hadengue A; Imhof BA; Frossard JL
J Pathol; 2006 Aug; 209(4):540-8. PubMed ID: 16767690
[TBL] [Abstract][Full Text] [Related]
13. The JAM family of junctional adhesion molecules.
Bazzoni G
Curr Opin Cell Biol; 2003 Oct; 15(5):525-30. PubMed ID: 14519386
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells.
Ozaki H; Ishii K; Horiuchi H; Arai H; Kawamoto T; Okawa K; Iwamatsu A; Kita T
J Immunol; 1999 Jul; 163(2):553-7. PubMed ID: 10395639
[TBL] [Abstract][Full Text] [Related]
15. JAM-A expression during embryonic development.
Parris JJ; Cooke VG; Skarnes WC; Duncan MK; Naik UP
Dev Dyn; 2005 Aug; 233(4):1517-24. PubMed ID: 15977176
[TBL] [Abstract][Full Text] [Related]
16. Expression of a recombinant protein of the platelet F11 receptor (F11R) (JAM-1/JAM-A) in insect cells: F11R is naturally phosphorylated in the extracellular domain.
Kedees MH; Babinska A; Swiatkowska M; Deitch J; Hussain MM; Ehrlich YH; Kornecki E
Platelets; 2005 Mar; 16(2):99-109. PubMed ID: 15823866
[TBL] [Abstract][Full Text] [Related]
17. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment.
Keiper T; Al-Fakhri N; Chavakis E; Athanasopoulos AN; Isermann B; Herzog S; Saffrich R; Hersemeyer K; Bohle RM; Haendeler J; Preissner KT; Santoso S; Chavakis T
FASEB J; 2005 Dec; 19(14):2078-80. PubMed ID: 16195363
[TBL] [Abstract][Full Text] [Related]
18. F11R/JAM-A: why do platelets express a molecule which is also present in tight junctions?
Kamola P; Babinska A; Przygodzki T
Platelets; 2023 Dec; 34(1):2214618. PubMed ID: 37246517
[TBL] [Abstract][Full Text] [Related]
19. Genomic structure, organization and promoter analysis of the human F11R/F11 receptor/junctional adhesion molecule-1/JAM-A.
Sobocki T; Sobocka MB; Babinska A; Ehrlich YH; Banerjee P; Kornecki E
Gene; 2006 Jan; 366(1):128-44. PubMed ID: 16337094
[TBL] [Abstract][Full Text] [Related]
20. Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution.
Schmitt MM; Fraemohs L; Hackeng TM; Weber C; Koenen RR
Atherosclerosis; 2014 Jun; 234(2):254-64. PubMed ID: 24704627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]